Trial Profile
Exchange from Beraprost to Selexipag study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Selexipag (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Acronyms EXCEL study
- 22 Feb 2017 New trial record